- $10.08bn
- $10.67bn
- $1.27bn
Tempus rises on acquisition of AI company Paige
U.S. RESEARCH ROUNDUP-Home Depot, News, Premier
U.S. RESEARCH ROUNDUP-Apollo, Blackstone, Nvidia
U.S. STOCKS ON THE MOVE-Centrus Energy, Tempus AI, Hagerty
Tempus AI rises on slightly lifting annual revenue forecast
Tempus AI Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tempus Reports Second Quarter 2025 Results
U.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
U.S. STOCKS ON THE MOVE-NIP Group, Hyatt, BioXcel Therapeutics
U.S. STOCKS ON THE MOVE-Circle, gold miners, silver miners
Tempus AI dips after boosted $650 mln convertible bond sale
U.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Tempus AI falls on planned $400 mln convertible bond sale
Brief: Tempus Ai Announces Proposed Convertible Senior Notes Offering
Brief: Tempus Announces Collaboration With Northwestern University's Abrams Research Center On Neurogenomics
Brief: Tempus Introduces xM, An Assay To Monitor Immunotherapy Response For Patients With Advanced Cancers
Brief: Tempus Introduces Fuses, A Program Designed To Transform Therapeutic Research And Build The Largest Diagnostic Platform Using Its Novel Foundation Model